FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Asparaginase Erwinia Chrysanthemi (Erwinaze)
Status: Currently in Shortage
»Date first posted: 10/14/2016
»Therapeutic Categories: Hematology; Oncology; Pediatric

Expand all

Jazz Pharmaceuticals, Inc. (Revised 06/27/2018)

Company Contact Information:
800-520-5568

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 5 vial carton (NDC 57902-249-05) Available Includes additional special handling instructions with product. Update to include use of 5-micron filter needle for reconstitution and 0.2 micron in-line filtration for IV. Please see Dear Healthcare Provider Letter.

Dear Healthcare Provider Letter

Other
ERWINAZE 10,000 IU lyophilized powder supplied in a clear 3 mL glass vial 1 vial (NDC 57902-249-01) Available Includes additional special handling instructions with product. Update to include use of 5-micron filter needle for reconstitution and 0.2 micron in-line filtration for IV. Please see Dear Healthcare Provider Letter.

Dear Healthcare Provider Letter

Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English